FeyeCon has extensive knowledge on the field of cannabinoids when it comes to process and products. Given the legislation in each country our technology often can better be applied in other regions instead of the Netherlands. We made it our business to export our technologies to the most appropriate regions and import from that place the best products. With this tactic we combine the best of both worlds, while still remaining in control of the quality. We sell our Over-The-Counter (OTC) products world-wide depending on the legislation in each country. As with the Cannabinoids API’s we have exclusive contracts with
OCHO Amsterdam and
Folium Europe to make this commercially viable either white label, branded or bulk.
The current OTC products do not contain THC and are rich in CBD and other minor cannabinoids, which are not psychoactive. Some of the products combine the cannabinoids with terpene profiles to reinforce certain qualities of the extracts. The product offer for dietary supplements consists of, intake oils, soft gels, gummies, from CBD broad spectrum; and for cosmetics, gels with heating and cooling effect, body-oils, lip-balm, from pure CBD or CBD broad spectrum. Commercialization is performed via
OCHO Amsterdam and
Folium Europe.
Through Folium Europe B.V. an independent Novel Food dossier has been submitted to the UK Food Standards Agency (FSA) for botanical broad-spectrum CBD, including all derived ingredients and white label finished products. The application is in de validation stage awaiting approval to move forward to the authorization stage.
